Cost-effectiveness of biphasic insulin aspart versus insulin glargine in patients with type 2 diabetes in China-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Cost-effectiveness of biphasic insulin aspart versus insulin glargine in patients with type 2 diabetes in China

Published:2010-10-12 Issue:11 Volume:27 Page:814-827
ISSN:0741-238X
Container-title:Advances in Therapy
language:en
Short-container-title:Adv Therapy

Author:

Palmer James L.,Beaudet Amélie,White Jeremy,Plun-Favreau Juliette,Smith-Palmer Jayne

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12325-010-0078-6.pdf

Reference45 articles.

1. Boutayeb A, Boutayeb S. The burden of non communicable diseases in developing countries. Int J Equity Health. 2005;4:2.

2. Schooling M, Leung GM, Janus ED, Ho SY, Hedley AJ, Lam TH. Childhood migration and cardiovascular risk. Int J Epidemiol. 2004;33:1219–1226.

3. Zhao W, Chen J. Implications from and for food cultures for cardiovascular disease: diet, nutrition and cardiovascular diseases in China. Asia Pacific J Clin Nutr. 2001;10:146–152.

4. Popkin BM. Nutrition in transition: the changing global nutrition challenge. Asia Pacific J Clin Nutr. 2001;10:S13–S18.

5. Palmer JL, Gibbs M, Scheijbeler HW, et al. Cost-effectiveness of switching to biphasic insulin aspart in poorly-controlled type 2 diabetes patients in China. Adv Ther. 2008;25:752–774.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Choice across 10 pharmacologic combination strategies for type 2 diabetes: a cost-effectiveness analysis;BMC Medicine;2020-12

2. A Real-World Anti-Diabetes Medication Cost Comparison Between Premixed Insulin Analogs and Long-Acting Insulin Analogs in Chinese Patients with Type 2 Diabetes: A Retrospective Database Analysis;Diabetes Therapy;2018-02-23

3. Economic Evaluation of Predominant Disease in Developing Countries;Social and Administrative Aspects of Pharmacy in Low- and Middle-Income Countries;2018

4. Health-related quality of life and health preference of Chinese patients with diabetes mellitus managed in primary care and secondary care setting: decrements associated with individual complication and number of complications;Health and Quality of Life Outcomes;2017-06-13

5. Diabetes: The Big Picture (Vol. 21, No. 4, Full Issue);Asia-Pacific Biotech News;2017-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3